InvestorsObserver
×
News Home

What is the Market's View on Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock's Price and Volume Trends Tuesday?

Tuesday, January 10, 2023 03:49 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock's Price and Volume Trends Tuesday?

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock has risen 2.26% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,neutral
Bio-Rad Laboratories, Inc. Class A Common Stock has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on BIO!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With BIO Stock Today?

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is trading at $431.96 as of 3:45 PM on Tuesday, Jan 10, an increase of $5.93, or 1.39% from the previous closing price of $426.03. The stock has traded between $425.46 and $441.40 so far today. Volume today is below average. So far 68,871 shares have traded compared to average volume of 166,505 shares. To see InvestorsObserver's Sentiment Score for Bio-Rad Laboratories, Inc. Class A Common Stock click here.

More About Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. Click Here to get the full Stock Report for Bio-Rad Laboratories, Inc. Class A Common Stock stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App